Interactions between scatter factors and their receptors: hints for therapeutic applications-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Interactions between scatter factors and their receptors: hints for therapeutic applications

Published:1998-10 Issue:13 Volume:12 Page:1267-1280
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Trusolino Livio¹,Pugliese Luisa¹,Comoglio Paolo M.¹

Affiliation:

1. Division of Molecular OncologyIRCCInstitute for Cancer ResearchUniversity of Torino School of Medicine 10060 Candiolo Torino Italy

Funder

Associazione Italiana per la Ricerca sul Cancro

Giovanni Armenise-Harvard Foundation

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fasebj.12.13.1267

Reference152 articles.

1. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures.

2. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility

3. Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement.

4. Biological and immunological properties of human hepatocyte growth factor from plasma of patients with fulminant hepatic failure

5. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes;Zarnegar R.;Cancer Res.,1989

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and toxicity of cabozantinib monotherapy in patients with advanced renal cell carcinoma: a Russian multicenter observational study;Journal of Modern Oncology;2023-08-10

2. The Emerging Role of c-Met in Carcinogenesis and Clinical Implications as a Possible Therapeutic Target;Journal of Oncology;2022-01-13

3. Elevated plasma levels of hepatocyte growth factor in rats experimentally envenomated with Bothrops jararaca venom: Role of snake venom metalloproteases;Toxicon;2019-04

4. Management of Adverse Events Associated with Cabozantinib Therapy in Renal Cell Carcinoma;The Oncologist;2017-11-16

5. Clinical use of cabozantinib in the treatment of advanced kidney cancer: efficacy, safety, and patient selection;OncoTargets and Therapy;2016-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3